Granted
The Veteran was granted a rating of 60 percent, but no higher, for laryngeal cancer residuals from October 2, 2023.
The deciding factor: FEV-1 of 56 to 70 percent predicted and daily inhalational or oral bronchodilator therapy prior to October 2, 2023, with FEV-1 of 55 percent and airway obstruction thereafter justified the 60 percent rating.
- Claimed conditions
- laryngeal cancer residuals
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- October 22, 2025
- Citation
- A25091131
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.